As of March 2024 Nevro has a market cap of $0.52 Billion. This makes Nevro the world's 5977th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.52 B | -32.54% |
2023 | $0.77 B | -44.47% |
2022 | $1.40 B | -50.42% |
2021 | $2.82 B | -52.52% |
2020 | $5.95 B | 60.74% |
2019 | $3.70 B | 215.03% |
2018 | $1.17 B | -42.46% |
2017 | $2.04 B | -2.13% |
2016 | $2.09 B | 10.01% |
2015 | $1.89 B | 97.6% |
2014 | $0.96 B |
On Mar 28th, 2024 the market cap of Nevro was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $221.62 B | 42,066.74% | ๐บ๐ธ USA |
Abiomed ABMD | $17.18 B | 3,168.86% | ๐บ๐ธ USA |
Intuitive Surgical ISRG | $141.45 B | 26,814.18% | ๐บ๐ธ USA |
Orthofix Medical
OFIX | $0.54 B | 3.34% | ๐บ๐ธ USA |